09-17-2007, 11:08 AM
|
 |
Lecturer
|
� |
Join Date: Apr 2006
Location: Propecia, CA
Posts: 1,852
|
|
C-Reactive Protein and Cancer
Quote:
Human C-reactive Protein Regulates Myeloma Tumor Cell Growth And Survival
Science Daily � Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. The research, published in the journal Cancer Cell, implicates C-reactive protein (CRP) as a potential target for cancer treatment.
CRP is a protein that is made in the liver and secreted systemically during the process of inflammation in response to the inflammatory cytokine IL-6. The blood level of CRP is elevated in patients with infections, inflammatory diseases, some cardiovascular diseases, and malignancies including multiple myeloma (MM). Dr. Qing Yi and Dr. Jing Yang from the M.D. Anderson Cancer Center and colleagues designed a series of studies to investigate whether human CRP might influence the growth and survival of MM tumor cells.
The researchers found that addition of CRP to cell cultures at levels observed in patients with MM promoted myeloma cell proliferation and protected myeloma cells from chemotherapy-induced apoptosis and apoptosis induced by IL-6 withdrawal. The protective influence of CRP was also validated in a mouse model of myeloma.
|
https://www.sciencedaily.com/releases...0910132856.htm
|
Linear Mode
